𝔖 Bobbio Scriptorium
✦   LIBER   ✦

1326 Immune-regulatory (FoxP3+)-T-cell tumor infiltration status is predictive of benefit from chemo-immunotherapy with gemcitabine, oxaliplatin, 5-FU/FA plus GM-CSF and aldesleukine (GOLFIG) in metastatic colon cancer patients

✍ Scribed by C. Remondo; P. Tagliaferri; M.S. Rotundo; P. Tassone; M.T. Del Vecchio; C. Migali; G. Francini; P. Correale


Book ID
119600260
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
69 KB
Volume
7
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.